Indeed, in agreement with our “Neuroenergetic hypothesis”, aberrant insulin signaling, and energy deficit may well be predisposing metabolic conditions for both the main pathological changes in AD, the Aβ deposition and tau hyperphosphorylation [18, 44, 45, 205] (Figure 2). The gene discussed is MAPT; the disease is Alzheimer disease.